J Clin Pathol 2006, 59:77–82.PubMedCrossRef 7. Saad RS, Lindner JL, Liu Y, Silverman JF: Lymphangiogenesis
in Esophageal Adenocarcinomas–Lymphatic Vessel Density as Prognostic PD-1/PD-L1 Inhibitor 3 mw Marker in Esophageal Adenocarcinoma. Am J Clin Pathol 2009, 131:92–98.PubMedCrossRef 8. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K: Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002, 2:573–583.PubMedCrossRef 9. Ding S, Li C, Lin S, Han Y, Yang Y, Zhang Y, Li L, Zhou L, Kumar S: Distinct roles of VEGF-A and VEGF-C in tumour metastasis of gastric carcinoma. Oncol Rep 2007,17(2):369–75.PubMed 10. Shida A, Fujioka S, Kobayashi K, Ishibashi Y, Nimura H, Mitsumori https://www.selleckchem.com/products/fosbretabulin-disodium-combretastatin-a-4-phosphate-disodium-ca4p-disodium.html N, Yanaga K: Expression of vascular endothelial growth factor(VEGF)-C and 4SC-202 chemical structure -D in gastric carcinoma. Int J Clin Oncol 2006, 11:38–43.PubMedCrossRef 11. Millauer
B, Wizigmann-Voos S, Schnürch H, Martinez R, Møller NP, Risau W, Ullrich A: High affinity VEGF binding and developmental expression suggest flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993, 71:835–846.CrossRef 12. Su JL, Chen PS, Chien MH, Chen PB, Chen YH, Lai CC, Hung MC, Kuo ML: Further evidence for expression and function of the VEGF-C/VEGFR-3 axis in cancer cells. Cancer cell 2008, 13:557–560.PubMedCrossRef 13. Rudnick DA, Pertmutter DH, Muglia LJ: Prostaglandins are required for CREB activation and cellular proliferation during liver regeneration. Proc Natl Acad Sci USA 2001, 98:8885–8890.PubMedCrossRef
14. Souza RF, Shewmake K, Beer DG, Cryer B, Spechler SJ: Selective inhibition of cyclooxygenase-2 suppresses growth and induced apoptosis in human esophageal adenocarcinoma cells. Cancer Res 2000, 60:5767–5772.PubMed 15. Pockaj BA, Basu GD, Pathangey LB, Gray RJ, Hernandez JL, Gendler SJ, Mukherjee P: Reduced T-cell and dendritic cell function is related to Cyclooxygenase-2 BCKDHA overexpression and prostaglandin E (2) secretion in patients with breast cancer. Ann Surg Oncol 2004, 11:328–339.PubMedCrossRef 16. Patel S, Chiplunkar S: Role of cyclooxygenase-2 in tumor progression and immune regulation in lung cancer. Indian J Biochem Biophys 2007, 44:419–428.PubMed 17. Ozuysal S, Bilgin T, Ozgur T, Celik N, Evrensel T: Expression of cyclooxygenase-2 in ovarian serous carcinoma: correlation with angiogenesis, nm23 expression and survival. Eur J Gynaecol Oncol 2009, 30:640–645.PubMed 18. Detmar M: Tumor angiogenesis. J Investig Dermatol Symp Proc 2000, 5:20–23.PubMedCrossRef 19. Sahin M, Sahin E, Gumuslu S: Cyclooxygenase-2 in Cancer and Angiogenesis Angiology. 2009, 60:242–253. 20. Liu J, Yu HG, Yu JP, Wang XL, Zhou XD, Luo HS: Overexpression of cyclooxygenase-2 in gastric cancer correlates with the high abundance of vascular endothelial growth factor-C and lymphatic metastasis. Med Oncol 2005, 22:389–397.PubMedCrossRef 21.